Portfolio

IHC Antibodies for Molecular Pathology

IHC Antibodies for Molecular Pathology

  

WE ARE A DISTRIBUTING PARTNER OF GenomeMe

 

From antigen design to validation, GenomeMe develops immunohistochemistry (IHC) antibodies targeting the critical markers you need to make your diagnosis with confidence and promises gold standard on cancer detection. GenomeMe is the only company in the world to develop a complete portfolio of 260+ IHC antibodies for clinically significant markers. GeneAb hybridomas are specifically designed, developed, screened, and validated for IHC. Our antibodies are tested by ELISA, WB, IHC and ICC to ensure uncompromising performance in specificity and sensitivity.

 


PRODUCT CATEGORIES  


RESOURCES


ANOPOLI'S TOPSELLERS


  

Order now via our contact form or feel free to request a trial sample to see how our products work for you! 

 

Date

11 March 2019

Tags

Diagnostics and Clinical Research, IHC and Antibodies